Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

47.42
-1.0300-2.13%
Post-market: 47.470.0498+0.11%19:59 EST
Volume:12.29M
Turnover:582.85M
Market Cap:210.50B
PE:13.10
High:47.75
Open:47.69
Low:47.03
Close:48.45
52wk High:93.80
52wk Low:43.08
Shares:4.44B
Float Shares:3.19B
Volume Ratio:1.20
T/O Rate:0.39%
Dividend:1.72
Dividend Rate:3.63%
EPS(TTM):3.62
EPS(LYR):3.62
ROE:60.70%
ROA:17.43%
PB:7.37
PE(LYR):13.10

Loading ...

Bridgewater Associates' 4Q Buying and Selling -- Barron's

Dow Jones
·
Feb 21

Novo Nordisk (0QIU) Receives a Buy from Kepler Capital

TIPRANKS
·
Feb 21

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO)

TIPRANKS
·
Feb 21

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Feb 21

Novo Nordisk nominates Jan van de Winkel and Ramona Sequeira to board

Reuters
·
Feb 20

Novo Nordisk A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
Feb 19

Novo Nordisk Expands Obesity Pipeline With New Phase 2 Trial for UBT251

TIPRANKS
·
Feb 18

Novo Nordisk Gets European Commission Approval for Higher-Dose Wegovy Injectable

MT Newswires Live
·
Feb 17

Barclays Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Feb 17

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Feb 17

Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows

Reuters
·
Feb 14

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
Feb 14

Novo Nordisk Advances Oral Semaglutide Into Youth Diabetes Care: What Investors Should Know

TIPRANKS
·
Feb 14

Eli Lilly Prepares for Oral Weight-Loss Drug Market, Building Stockpiles Ahead of FDA Decision

Stock News
·
Feb 13

Novo Nordisk price target lowered to DKK 360 from DKK 415 at Berenberg

TIPRANKS
·
Feb 13

Market Chatter: Novo Nordisk to Manufacture Wegovy in Ireland Facility

MT Newswires Live
·
Feb 13

Novo Nordisk Expands GLP-1 Ambitions With Completed Liver and Alcohol Use Trial

TIPRANKS
·
Feb 13

Novo Nordisk Initiates Lawsuit Against Hims as Regulators Scrutinize Compounded GLP-1 Drugs

Deep News
·
Feb 12

BUZZ-Jefferies lifts Novo Nordisk to 'hold,' sees downside risks now priced in

Reuters
·
Feb 12

Jefferies Upgrades Novo Nordisk to Hold From Underperform, Adjusts Price Target to $43.90 From $42.10

MT Newswires Live
·
Feb 12